Researchers are looking for monoclonal antibodies (MABS) and other biotechnological approaches, which will increase the efficiency, safety, and availability of anti-venom. By focusing on human-based treatments, these innovations promise more accuracy and minor side effects for patients suffering from toxic animals and ensure rapid improvement and high quality of life. https://www.coherentmarketinsights.com/blog/innovative-technologies-and-research-by-anti-venom-manufacturers-2078